The analysis of GBM cell lines, ex vivo primary tumor cells, and GBM tissue biopsies showed that GBM tumors express both cannabinoid receptors CB1 and CB2, with high-grade tumors expressing high levels of CB2. The gene discussed is CNR2; the disease is glioblastoma.